Evaluating the Effectiveness of the Moving to Emptiness Technique in Reducing Counsellors' Compas… (NCT07718035) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluating the Effectiveness of the Moving to Emptiness Technique in Reducing Counsellors' Compassion Fatigue
60 participantsStarted 2026-07-27
Plain-language summary
The goal of this clinical trial is to learn if Moving to Emptiness Technique (MET) works to treat counselors' compassion fatigue (CF). It will also learn about the effectiveness of MET on counselors' professional quality of life and counselling self-estimate. The main questions it aims to answer are:
• Does MET reduce counselors' compassion fatigue? Researchers will compare MET intervention to a waitlist control group to see if MET works to treat counselor burnout.
Participants will:
* Receive MET intervention for 4 sessions, once a week, 50 minutes per session.
* Fill the questionnaires tests at three timepoints: before the intervention, immediately after the intervention phase and 4 weeks after the intervention.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults (aged 18-60)
* Counsellors who have worked in the counselling profession for at least one year
* Counsellors who self-report experiencing CF symptoms
* Able to commit to attend the 4 weekly online sessions of 50 minutes' duration
* Counsellors based in China
Exclusion Criteria:
* Counsellors have received psychological therapy for their CF within the last 6 months
* Counsellors who intend to participate in other psychological therapy for their CF besides MET during the study duration
* Counsellors who self-report experiencing a traumatic event within past one year
* Counsellors who self-report severe mental illness within past one year
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.